Benefits for Industry
The TWINFUSYON project can bring benefits to businesses:
- Support on enhanced knowledge in novel 2D-materials (graphene and dicalchogenides) with enhanced capabilities for development of new biosensing strategies;
- Benefit from identified best-practices in smart analytics and predictive models to strengthen capacity of understanding bio-systems and developing new processes/products;
- Access to facilities and associated expertise;
- Improvement of technology capacity transforming the elaborated concepts into novel optronic biosensors;
- Utilise educational and training excellence;
- Access a global pool of talented students;
- Short or long term secondments of academics into industry;
- Highly-qualified, innovative work force in the field of optronic biosensing;
- Access to information on the latest research achievements in materials, procedures and devices related to optronic biosensing;
- Collaborate with world-renowned academics and research centres.
COMPANIES that might be interested in collaboration
Plasmonic and optronic biosensors have a huge impact in the medical, environmental, forensic and food monitoring protocols and significantly contribute to the spreading of alternative, fast and reliable analytical methods for food safety control. This will help:
- Manufacturers of Lab-on-chip disposable biosensors with integrated readout for medical diagnostics would radically cut healthcare costs;
- Manufacturers of graphene and other 2D materials, and of plasmonic nanoparticles;
- Manufacturers of diagnostic tools;
- Industries and distributors to provide safer products;
- End-users and small distributors in the area of electronics, photonics, biosensingto verify the quality of their everyday products public regulatory bodies to improve the quality of the control tests while reducing the assay costs.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 692034. Disclaimer: This website and included materials reflect only the author’s view and the Research Executive Agency is not responsible for any use that may be made of the information it contains. | |